Sub Banner Image

Why Rubrik Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket

Pre-Market Outlook

Avi Kapoor

·

March 14, 2025

·

Benzinga

Shares of Rubrik, Inc. (NYSE:RBRK) rose sharply in today's pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued first-quarter guidance above estimates.

Rubrik reported quarterly losses of 61 cents per share, which beat the analyst consensus estimate for losses of 80 cents. Quarterly revenue clocked in at $258.1 million, which beat the analyst consensus estimate of $233.1 million.

Rubrik shares climbed 20.8% to $66.84 in the pre-market trading session.

Here are some other stocks moving in pre-market trading.

Gainers

  • Radius Recycling, Inc. (NASDAQ:RDUS) rose 108.7% to $28.51 in pre-market trading after the company agreed to be acquired by US subsidiary of Toyota Tsusho for $30.00 per share in cash.
  • Applied Optoelectronics, Inc. (NASDAQ:AAOI) gained 56.5% to $24.83 in pre-market trading after the company announced a warrant issuance agreement transaction with Amazon for 7,945,399 shares.
  • MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) gained 48.6% to $0.91 in pre-market trading. MEDIROM Mother Labs executive made an additional investment in Mother Labs’ Series A financing at a pre-money valuation of JPY9 billion.
  • Cellectis S.A. (NASDAQ:CLLS) gained 40.3% to $1.81 in pre-market trading after the company announced upbeat financial results for the fourth quarter.
  • Bit Origin Ltd (NASDAQ:BTOG) gained 37.2% to $0.3743 in pre-market trading after declining 26% on Thursday.
  • Digital Ally, Inc. (NASDAQ:DGLY) gained 23.2% to $0.0978 in pre-market trading. Digital Ally has been granted six new patents covering diverse sectors.
  • TransCode Therapeutics, Inc. (NASDAQ:RNAZ) rose 19% to 0.8827. TransCode Therapeutics, on Thursday, announced Safety Review Committee approval to open a fourth cohort of its Phase I/II Clinical trial of TTX-MC138.
  • DocuSign, Inc. (NASDAQ:DOCU) gained 12.2% to $83.75 in pre-market following better-than-expected fourth-quarter financial results.
  • Ulta Beauty, Inc. (NASDAQ:ULTA) rose 7% to $336.26 in pre-market trading as the company reported stronger-than-expected fourth-quarter financial results. Ulta Beauty expects fiscal year 2025 revenue of $11.5 billion to $11.6 billion versus estimates of $11.67 billion, according to Benzinga Pro. The company anticipates full-year earnings of $22.50 to $22.90 per share versus estimates of $23.50 per share.

Losers

  • Xponential Fitness, Inc. (NYSE:XPOF) shares fell 30.8% to $8.39 in pre-market trading after the company announced fourth-quarter results.
  • Linkage Global Inc (NASDAQ:LGCB) declined 21.8% to $0.1797 in pre-market trading.
  • Septerna, Inc. (NASDAQ:SEPN) dipped 21.4% to $5.02 in pre-market trading after falling 5% on Thursday.
  • Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) fell 15.1% to $3.71 in pre-market trading.
  • Icon Energy Corp. (NASDAQ:ICON) shares fell 14.7% to $0.1160 in pre-market trading. ICON Energy received non-compliance letter from the Nasdaq.
  • Regencell Bioscience Holdings Limited (NASDAQ:RGC) fell 13.4% to $12.20 in pre-market trading. Relevant Gold closed second tranche of upsized $8.5 million non-brokered private placement led by strategic investors Kinross and Bollinger.
  • ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) fell 11.8% to $0.3572 in today's pre-market trading. ImmunoPrecise Antibodies shares gained over 11% on Thursday after the company announced a strategic partnership to advance antibody-drug conjugates and bispecific antibodies for cancer.
  • SenesTech, Inc (NASDAQ:SNES) shares tumbled 10% to $2.16 in pre-market trading after gaining 5% on Thursday. SenesTech recently reported better-than-expected quarterly EPS results.
  • SI-BONE, Inc. (NASDAQ:SIBN) fell 8.2% to $13.51 in pre-market trading. SI-BONE recently reported better-than-expected fourth-quarter EPS results and issued FY25 sales guidance above estimates.
  • XPeng Inc. (NYSE:XPEV) shares dipped 5.4% to $23.99 in pre-market trading. XPeng recenty announced to spend up to $13.8 billion on humanoid robots.

Now Read This:

More from

Benzinga

More

Pre-Market Outlook

Articles

Trending News

Enjoy premium content in your inbox.

You're in! Check your email to learn more.
Oops! Something went wrong while submitting the form.